journal article·2017-10-26Open access

miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway

Anquan Shang, Wen-Ying Lu, Man Yang, Cheng Zhou, Hong Zhang, Zheng-Xin Cai, Wei-Wei Wang, Wan-Xiang Wang, Gui-Qi Wu

Abstract

Oral cancer remains a major public concern with considerable socioeconomic impact in the world, especially in southeast Asia. Despite substantial advancements have been made in treating oral cancer, the five-year survival rate for OSCC remained undesirable, and 35-55% patients developed recurrence within two years even with multimodality therapeutic strategies. Hence, identification of novel biomarkers for diagnosis and evaluating clinical outcome is of vital importance. MicroRNAs are 22-24 nt non-coding RNAs that could bind to 3' UTR of target mRNAs, thereby inducing degradation of mRNA or inhibiting translation. Due to its implication in regulation of post-transcriptional processes, the role of miRNAs in malignancies has been extensively studied, among which the discovery of functional miR-9 in oral squamous cell carcinoma (OSCC) remained to be elucidated. We first demonstrated that miR-9 was down-regulated in 21 OSCC patients, and we further found that forced expression of miR-9 could result in deterred cell proliferation and decreased ability to migrate and form colonies. Flow cytometry displayed cell-cycle arrested at G0/G1 phase. We next used Targetscan to predict target genes of miR-9. CDK6, a protein highly implicated in cell cycle control, was chosen for verification. Down-regulation of CDK6 and Cyclin D1 in Tca8113 transfected with miR-9 mimics indicate that the complex formed by both proteins may be the effector of the antiproliferative function of miR-9 in OSCCs. Considering small molecules are developed to target CDK4/6, our finding may provide valuable scientific evidence for research and development of therapies and diagnostic methodology in OSCCs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Circular RNAs in diseases · Lung Cancer Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Laboratory Medicine,, Tongji Hospital of Tongji University, Shanghai, China;

Department of Laboratory Medicine, The Sixth People’s Hospital of Yancheng City, Yancheng, Jiangsu, China;

Department of Laboratory Medicine, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu, China;

School of Biology & Basic Medical Sciences, Medical College of Soochow University, Suzhou, Jiangsu, China;

Department of Pathology, The First People’s Hospital of Yancheng City, Yancheng, Jiangsu, China;

Department of Pathology, The Sixth People’s Hospital of Yancheng City, Yancheng, Jiangsu, China;

Department of Laboratory Medicine, The First People’s Hospital of Yancheng City, Yancheng, Jiangsu, China;

Department of General Surgery, The Sixth People’s Hospital of Yancheng City, Yancheng, Jiangsu, China

Funding

Strengthening the Construction of Public Health System · Medical Science and Technology Development Program

References (53)

Show source-provided references
1. Codes CM, Information P, August R. International Classification of Diseases (ICD) for Oncology; 2012. [no volume].
2. 10.1186/1756-9966-28-6410.1186/1756-9966-28-64 ↗
3. 10.1046/j..2003.com122.x10.1046/j..2003.com122.x ↗
4. Gombos K · Anticancer Res · 2013 · 33 · 1511
5. 10.1016/S0140-6736(08)60728-X10.1016/S0140-6736(08)60728-X ↗
6. 10.1093/nar/gkm64110.1093/nar/gkm641 ↗
7. 10.1016/j.pbi.2004.01.00610.1016/j.pbi.2004.01.006 ↗
8. 10.1146/annurev.med.59.053006.10470710.1146/annurev.med.59.053006.104707 ↗
9. 10.1016/j.gpb.2012.10.00110.1016/j.gpb.2012.10.001 ↗
10. 10.1016/j.molmed.2014.06.00510.1016/j.molmed.2014.06.005 ↗
11. 10.1038/nrc199710.1038/nrc1997 ↗
12. 10.1158/1078-0432.CCR-08-305310.1158/1078-0432.CCR-08-3053 ↗
13. 10.1371/journal.pone.009519310.1371/journal.pone.0095193 ↗
14. 10.1002/ijc.2358310.1002/ijc.23583 ↗
15. 10.1016/j.bbrc.2012.12.09710.1016/j.bbrc.2012.12.097 ↗
16. 10.1002/ijc.2463810.1002/ijc.24638 ↗
17. 10.1002/path.296410.1002/path.2964 ↗
18. 10.1016/j.canlet.2008.07.03810.1016/j.canlet.2008.07.038 ↗
19. 10.1038/onc.2010.42510.1038/onc.2010.425 ↗
20. Lucas JJ · Mol Cancer Res · 2004 · 2 · 10510.1158/1541-7786.105.2.2 ↗
21. Tieri P, Nardini C, Dent JE. Multi-omic data integration; 2015.10.3389/978-2-88919-648-7 ↗
22. 10.1158/1055-9965.EPI-12-063510.1158/1055-9965.EPI-12-0635 ↗
23. Ma L · Nat Cell Biol · 2010 · 12 · 36
24. 10.1038/bjc.2015.17010.1038/bjc.2015.170 ↗
25. 10.1002/ijc.2592310.1002/ijc.25923 ↗
26. 10.4161/cbt.7.7.620810.4161/cbt.7.7.6208 ↗
27. 10.1186/1756-9966-28-8210.1186/1756-9966-28-82 ↗
28. 10.1186/1476-4598-7-3510.1186/1476-4598-7-35 ↗
29. 10.1038/onc.2015.40710.1038/onc.2015.407 ↗
30. 10.1242/dev.09174410.1242/dev.091744 ↗
31. 10.1038/ncb1109-127510.1038/ncb1109-1275 ↗
32. 10.1038/3510606510.1038/35106065 ↗
33. 10.1093/jnci/dju22110.1093/jnci/dju221 ↗
34. 10.1038/nrc260210.1038/nrc2602 ↗
35. 10.1038/sj.onc.120991110.1038/sj.onc.1209911 ↗
36. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
37. 10.1038/onc.2013.13710.1038/onc.2013.137 ↗
38. 10.3389/fcell.2015.0001610.3389/fcell.2015.00016 ↗
39. 10.1038/sj.cr.729003110.1038/sj.cr.7290031 ↗
40. 10.1158/1535-7163.MCT-05-038310.1158/1535-7163.MCT-05-0383 ↗
41. 10.18632/oncotarget.154110.18632/oncotarget.1541 ↗
42. 10.1146/annurev.cellbio.13.1.26110.1146/annurev.cellbio.13.1.261 ↗
43. 10.1101/gad.7.3.33110.1101/gad.7.3.331 ↗
44. 10.1016/S0092-8674(00)81519-610.1016/S0092-8674(00)81519-6 ↗
45. 10.1016/j.cell.2005.09.04410.1016/j.cell.2005.09.044 ↗
46. 10.1074/jbc.M110.10816710.1074/jbc.M110.108167 ↗
47. 10.1016/j.jmb.2013.09.03110.1016/j.jmb.2013.09.031 ↗
48. 10.1038/nrd290710.1038/nrd2907 ↗
49. 10.1101/gad.12.15.224510.1101/gad.12.15.2245 ↗
50. Chilosi M · Am J Pathol · 1998 · 152 · 209
51. 10.1038/labinvest.378009310.1038/labinvest.3780093 ↗
52. 10.1073/pnas.060372810310.1073/pnas.0603728103 ↗
53. 10.1038/sj.leu.240502810.1038/sj.leu.2405028 ↗